DGFCX
Price
$29.77
Change
+$0.16 (+0.54%)
Updated
Dec 26 closing price
Net Assets
954.69M
RWIFX
Price
$71.99
Change
+$0.08 (+0.11%)
Updated
Dec 26 closing price
Net Assets
142.32B
Interact to see
Advertisement

DGFCX vs RWIFX

Header iconDGFCX vs RWIFX Comparison
Open Charts DGFCX vs RWIFXBanner chart's image
Davis Global C
Price$29.77
Change+$0.16 (+0.54%)
VolumeN/A
Net Assets954.69M
American Funds Capital World Gr&Inc R5
Price$71.99
Change+$0.08 (+0.11%)
VolumeN/A
Net Assets142.32B
DGFCX vs RWIFX Comparison Chart in %
View a ticker or compare two or three
VS
DGFCX vs. RWIFX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGFCX is a Hold and RWIFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIFX has more cash in the bank: 142B vs. DGFCX (955M). RWIFX pays higher dividends than DGFCX: RWIFX (1.59) vs DGFCX (0.28). DGFCX was incepted earlier than RWIFX: DGFCX (21 years) vs RWIFX (24 years). DGFCX (1.76) is less costly to investors than RWIFX (0.46). DGFCX is a more actively managed with annual turnover of: 34.00 vs. RWIFX (27.00). RWIFX has a lower initial minimum investment than DGFCX: RWIFX (250) vs DGFCX (1000). DGFCX annual gain was more profitable for investors over the last year : 20.23 vs. RWIFX (12.66). RWIFX return over 5 years is better than : 32.78 vs. DGFCX (9.88).
DGFCXRWIFXDGFCX / RWIFX
Total Expense Ratio1.760.46383%
Annual Report Gross Expense Ratio1.760.46383%
Fund Existence21 years24 years-
Gain YTD22.10814.720150%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets955M142B1%
Annual Yield % from dividends0.281.5917%
Returns for 1 year20.2312.66160%
Returns for 3 years53.2847.45112%
Returns for 5 years9.8832.7830%
Returns for 10 years75.6775.72100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRVA24.130.44
+1.86%
Privia Health Group
ENGN9.500.05
+0.53%
enGene Holdings
PFG89.38-0.21
-0.23%
Principal Financial Group
NCT0.23N/A
-0.95%
Intercont (Cayman) Limited
FATE1.00-0.01
-0.99%
Fate Therapeutics